Publisher: Kenneth Kee
Publication Date: March 27, 2018
Binding: Kobo eBook
This book describes Myelodysplastic Syndrome (Refractory Anemia), Diagnosis and Treatment and Related Diseases
Myelodysplastic syndrome (MDS) is a cluster of disorders when the blood cells formed in the bone marrow do not mature into healthy cells.
This leaves the person with fewer healthy blood cells in the body, mainly immature blood cells.
The blood cells that do not matured may not work properly.
Myelodysplastic syndrome (MDS) can be a form of cancer.
In about a third of people, MDS may become acute myeloid leukemia.
Stem cells in bone marrow form different types of blood cells.
With MDS, the DNA in stem cells becomes injured.
Since the DNA is injured, the stem cells cannot produce healthy blood cells.
Risk factors for MDS are:
1.Certain genetic disorders
2.Exposure to environmental or industrial chemicals, fertilizers, pesticides, solvents, or heavy metals
Previous cancer treatment increases the risk for MDS.
This is called secondary or treatment-linked MDS.
1.Certain chemotherapy drugs
People who have stem cell transplants may form MDS because they also have been given high doses of chemotherapy.
MDS normally happens in adults age of 60 years and older.
It is more frequent in men.
Early phase MDS often has no symptoms.
MDS is often found during other blood tests.
People with very low blood counts often have symptoms.
Symptoms are dependent on the type of blood cell affected, and they are:
1.Weakness or tiredness due to anemia
2.Shortness of breath
3.Easy bruising and bleeding
4.Small red or purple pinpoint dots under the skin caused by bleeding
5.Frequent infections and fever
People with MDS have a shortage of blood cells.
MDS may reduce the number of one or more of ...